Cold Spring Harbor Laboratory Professor Hiro Furukawa and postdoc Hyunook Kang prove the existence of a mysterious brain receptor known as GluN1- 2B -2D.
“If cannabis use ‘causes’ schizophrenia, it is absolutely impossible that the rate of schizophrenia would not be going up ...
New research provides the first direct evidence that brain lesions causing secondary psychosis map to a common brain circuit ...
Our study investigated the brain circuits involved in psychosis-a condition characterized by delusions, hallucinations, ...
If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...
Acadia Pharmaceuticals' forecasted revenues top $1bn in 2025. Find out why ACAD stock is a "Buy" with its profitable outlook ...
Heavy weed use may be far more dangerous than people realize, according to a pair of studies published in JAMA Network ...
Two new Canadian studies are the largest to date looking at death rates and psychosis associated with cannabis use disorder.
The sad tale of a Murewa granny –Newsday Zimbabwe d NEAR the majestic Nyaguwe River, which separates Goromonzi and Murewa ...
to manufacture both the API and Drug Formulation of Pimavanserin, a 34 mg capsule. Pimavanserin is an atypical antipsychotic used for the treatment of hallucinations and delusions associated with ...
AbbVie Inc.'s stock rose 7.7% Friday to lead S&P 500 gainers after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology drugs delivered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback